Scarica l'app Stockscreener
88.50
0.01%
-0.0053
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$88.51
Aprire:
$89
Volume 24 ore:
1.24M
Relative Volume:
0.78
Capitalizzazione di mercato:
$17.53B
Reddito:
$7.83B
Utile/perdita netta:
$825.20M
Rapporto P/E:
21.55
EPS:
4.1067
Flusso di cassa netto:
$1.05B
1 W Prestazione:
-11.99%
1M Prestazione:
-10.66%
6M Prestazione:
-5.98%
1 anno Prestazione:
-18.57%
Intervallo 1D:
$87.42
$90.16
Intervallo di 1 settimana:
$85.33
$103.70
Portata 52W:
$85.33
$114.72
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
88.51 | 17.54B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
125.80 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
99.90 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
91.99 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.59 | 47.84B | 5.88B | 1.34B | 577.90M | 2.3455 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet (NYSE:ZBH) Given New $101.00 Price Target at Royal Bank Of Canada - MarketBeat
Should I buy Zimmer Biomet Holdings Inc. stock before earnings seasonJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Zimmer Biomet's (ZBH) Neutral Rating Reiterated at JPMorgan Chase & Co. - MarketBeat
Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London - PR Newswire
Strategies to average down on Zimmer Biomet Holdings Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Sound Shore Management Inc CT Buys 128,772 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Bryn Mawr Trust Advisors LLC Has $5.77 Million Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Bank of New York Mellon Corp Decreases Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Chart overlay techniques for tracking Zimmer Biomet Holdings Inc.Weekly Stock Analysis & Daily Price Action Insights - newser.com
How Zimmer Biomet Holdings Inc. stock valuation compares with sectorJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Zimmer Biomet (NYSE:ZBH) Announces Earnings Results - MarketBeat
Zimmer Biomet Holdings (ZBH): UBS Lowers Price Target to $88 | Z - GuruFocus
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain free cash flowInsider Selling & Long-Term Capital Growth Ideas - newser.com
Zimmer Biomet (NYSE:ZBH) Hits New 52-Week Low After Analyst Downgrade - MarketBeat
Zimmer Biomet (ZBH) Gives Up 15% on Weak Q3 - MSN
Zimmer Biomet (NYSE:ZBH) Given New $112.00 Price Target at BTIG Research - MarketBeat
Zimmer Biomet Holdings (ZBH) Analyst Rating Update: Barclays Adj - GuruFocus
Truist Cuts Price Target on Zimmer Biomet Holdings to $98 From $104, Keeps Hold Rating - MarketScreener
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2025 Earnings Call Transcript - MSN
Zimmer Biomet Holdings (ZBH) Downgraded by JP Morgan, Price Targ - GuruFocus
Citigroup Adjusts Price Target on Zimmer Biomet Holdings to $98 From $104, Maintains Neutral Rating - MarketScreener
Stifel Adjusts Price Target on Zimmer Biomet Holdings to $110 From $118, Maintains Buy Rating - MarketScreener
Deutsche Bank Adjusts Price Target on Zimmer Biomet Holdings to $88 From $97, Maintains Hold Rating - MarketScreener
Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $103 From $113, Maintains Outperform Rating - MarketScreener
Bernstein Adjusts Price Target on Zimmer Biomet Holdings to $97 From $105, Maintains Market Perform Rating - MarketScreener
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $104 From $105, Maintains Underweight Rating - MarketScreener
Jefferies Adjusts Price Target on Zimmer Biomet to $100 From $110, Maintains Hold Rating - MarketScreener
TD Cowen Adjusts Price Target on Zimmer Biomet to $99 From $104, Maintains Hold Rating - MarketScreener
How interest rate cuts could boost Zimmer Biomet Holdings Inc. stock2025 Performance Recap & Fast Entry High Yield Tips - newser.com
Zimmer Biomet (NYSE:ZBH) Issues FY 2025 Earnings Guidance - MarketBeat
Can Zimmer Biomet Holdings Inc. (ZIM) stock sustain revenue momentumJuly 2025 Action & Community Consensus Picks - newser.com
Equity Investment Corp Increases Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet reports Q3 adjusted EPS $1.90, consensus $1.86 - Yahoo Finance
Why Zimmer Biomet Holdings Inc. stock is a must watch tickerPortfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Zimmer Biomet Q3 2025 net sales up 9.7% to USD 2.001 billion - Medical Buyer
Is Zimmer Biomet Holdings Inc. (ZIM) stock positioned for secular growthJuly 2025 Summary & Daily Stock Momentum Reports - newser.com
JPMorgan Downgrades Zimmer Biomet to Neutral From Overweight, Adjusts PT to $100 From $115 - MarketScreener
Zimmer Biomet (ZBH) One-Off $304.6M Loss Raises Questions on Margin Trends and Valuation Narratives - Yahoo Finance
Tools to monitor Zimmer Biomet Holdings Inc. recovery probability2025 Performance Recap & Community Verified Watchlist Alerts - newser.com
Zimmer Biomet stock price target lowered to $120 by Citizens - Investing.com
Zimmer Biomet Holdings Inc. stock momentum explainedJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-11-06 03:18:59 - newser.com
Versor Investments LP Invests $316,000 in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet narrows 2025 organic revenue growth outlook to 3.5%-4% amid international headwinds and product momentum - MSN
Zimmer Biomet Holdings, Inc. $ZBH Shares Purchased by Assetmark Inc. - MarketBeat
Applying big data sentiment scoring on Zimmer Biomet Holdings Inc.Buy Signal & Risk Controlled Stock Alerts - newser.com
Zimmer Biomet (NYSE:ZBH) S&P 500 ETF Sparks MedTech Growth - Kalkine Media
Order flow analysis tools used on Zimmer Biomet Holdings Inc.July 2025 Earnings & Safe Capital Growth Tips - newser.com
What makes Zimmer Biomet Holdings Inc. stock attractive to growth fundsForecast Cut & Advanced Swing Trade Entry Plans - newser.com
Zimmer Biomet Reports Strong Q3 2025 Earnings - TipRanks
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.48%
1.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):